These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19185882)

  • 1. Increasing number of stroke specialists should contribute to utilization of IV rt-PA: results of questionnaires from 1,466 hospitals in Japan.
    Iguchi Y; Kimura K; Shibazaki K; Iwanaga T
    J Neurol Sci; 2009 Apr; 279(1-2):66-9. PubMed ID: 19185882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The number of stroke physicians is the key to preparing IV rt-PA.
    Iguchi Y; Kimura K; Shibazaki K; Aoki J
    Cerebrovasc Dis; 2009; 28(5):460-7. PubMed ID: 19738375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large numbers of stroke physicians should be used to treat large numbers of stroke patients with IV rt-PA.
    Iguchi Y; Kimura K; Shibazaki K
    J Neurol Sci; 2011 Mar; 302(1-2):81-4. PubMed ID: 21195435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
    Yong M; Diener HC; Kaste M; Mau J
    Cerebrovasc Dis; 2007; 24(4):349-54. PubMed ID: 17690547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing.
    Wang Y; Wu D; Zhao X; Ma R; Guo X; Wang C; Liu L; Zhao W; Wang Y
    Surg Neurol; 2009 Aug; 72 Suppl 1():S2-7. PubMed ID: 18423545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of lesion side on acute stroke treatment.
    Di Legge S; Fang J; Saposnik G; Hachinski V
    Neurology; 2005 Jul; 65(1):81-6. PubMed ID: 16009890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.
    Deng YZ; Reeves MJ; Jacobs BS; Birbeck GL; Kothari RU; Hickenbottom SL; Mullard AJ; Wehner S; Maddox K; Majid A;
    Neurology; 2006 Feb; 66(3):306-12. PubMed ID: 16476927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-hospital delay in the use of intravenous rt-PA for acute ischemic stroke in Japan.
    Inatomi Y; Yonehara T; Hashimoto Y; Hirano T; Uchino M
    J Neurol Sci; 2008 Jul; 270(1-2):127-32. PubMed ID: 18395754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
    Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
    Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do centres with well-developed protocols, training and infrastructure have higher rates of thrombolysis for acute ischaemic stroke?
    van Wijngaarden JD; Dirks M; Niessen LW; Huijsman R; Dippel DW
    QJM; 2011 Sep; 104(9):785-91. PubMed ID: 21613273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "drip-and-ship" approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center.
    Silverman IE; Beland DK; Chhabra J; McCullough LD
    Conn Med; 2005; 69(10):613-20. PubMed ID: 16381108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis in right versus left hemispheric stroke.
    Blondin NA; Staff I; Lee N; McCullough LD
    J Stroke Cerebrovasc Dis; 2010; 19(4):269-72. PubMed ID: 20471856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update in thrombolytic therapy.
    Hacke W; Ringleb P; Stingele R
    Rev Neurol (Paris); 1999; 155(9):662-5. PubMed ID: 10528345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke.
    Kunisawa S; Kobayashi D; Lee J; Otsubo T; Ikai H; Yokota C; Minematsu K; Imanaka Y
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):724-31. PubMed ID: 23910512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
    Mendioroz M; Fernández-Cadenas I; Alvarez-Sabín J; Rosell A; Quiroga D; Cuadrado E; Delgado P; Rubiera M; Ribó M; Molina C; Montaner J
    Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Brain attack in Japan, now and future].
    Kobayashi S
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1049-51. PubMed ID: 12235792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of comprehensive stroke care capacity on the hospital volume of stroke interventions: a nationwide study in Japan: J-ASPECT study.
    Iihara K; Nishimura K; Kada A; Nakagawara J; Toyoda K; Ogasawara K; Ono J; Shiokawa Y; Aruga T; Miyachi S; Nagata I; Matsuda S; Ishikawa KB; Suzuki A; Mori H; Nakamura F;
    J Stroke Cerebrovasc Dis; 2014; 23(5):1001-18. PubMed ID: 24103675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality improvement in acute stroke: the New York State Stroke Center Designation Project.
    Gropen TI; Gagliano PJ; Blake CA; Sacco RL; Kwiatkowski T; Richmond NJ; Leifer D; Libman R; Azhar S; Daley MB;
    Neurology; 2006 Jul; 67(1):88-93. PubMed ID: 16832083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.